International safety notice

TELIGEN 100 Implantable Defibrillator Cardioverter - Model: E102 - Registration: 10341350535 - Risk Class IV

Brazil / Anvisa · BRA · Sep 29, 2014

Key facts

Title TELIGEN 100 Implantable Defibrillator Cardioverter - Model: E102 - Registration: 10341350535 - Risk Class IV
Regulator Brazil / Anvisa
Country BRA
Brand TELIGEN 100 Implantable Cardioverter Defibrillator - Model: E102 - Registration: 10341350535 - Risk Class IV - (AFFECTED SERIES ATTACHED)
Manufacturer DETENTOR DO REGISTRO NO BRASIL BOSTON SCIENTIFIC DO BRASIL LTDA CNPJ 01513946000114 AV DAS NAÇÕES UNIDAS 21476 SANTO AMARO VILA ALMEIDA SÃO PAULOSP FONEFAX 11585325481158532663 EMAIL REGAFFAIRSBRAZILBSCICOM FABRICANTE BOSTON SCIENTIFIC CLONMEL LIMITED CASHEL ROADCLONMEL CO TIPPERARY IRLANDA
Models 10341350535
Date Sep 29, 2014
Regulator page anvisa.gov.br

At a glance

  • No Recall
  • No Field safety notice
  • 1–9 Matching device models in FDA data
  • 1–9 Matching catalog numbers in FDA data

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices